PL1853308T3 - Podawany drogą pokarmową preparat farmaceutyczny dla ryb, jego sposób wytwarzania oraz jego zastosowanie - Google Patents

Podawany drogą pokarmową preparat farmaceutyczny dla ryb, jego sposób wytwarzania oraz jego zastosowanie

Info

Publication number
PL1853308T3
PL1853308T3 PL05818637T PL05818637T PL1853308T3 PL 1853308 T3 PL1853308 T3 PL 1853308T3 PL 05818637 T PL05818637 T PL 05818637T PL 05818637 T PL05818637 T PL 05818637T PL 1853308 T3 PL1853308 T3 PL 1853308T3
Authority
PL
Poland
Prior art keywords
preparation
production method
administered orally
fish
pharmaceutical preparation
Prior art date
Application number
PL05818637T
Other languages
English (en)
Inventor
Malte Adelmann
Dieter Fichtner
Bodo Lange
Werner Weitschies
Original Assignee
Riemser Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riemser Pharma Gmbh filed Critical Riemser Pharma Gmbh
Publication of PL1853308T3 publication Critical patent/PL1853308T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Farming Of Fish And Shellfish (AREA)
PL05818637T 2005-03-02 2005-12-13 Podawany drogą pokarmową preparat farmaceutyczny dla ryb, jego sposób wytwarzania oraz jego zastosowanie PL1853308T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005010288A DE102005010288A1 (de) 2005-03-02 2005-03-02 Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung
EP05818637A EP1853308B1 (de) 2005-03-02 2005-12-13 Pharmazeutisches, oral applizierbares präparat zur behandlung von fischen, herstellungsverfahren für dieses und seine verwendung
PCT/EP2005/013497 WO2006092168A1 (de) 2005-03-02 2005-12-13 Pharmazeutisches, oral applizierbares präparat zur behandlung von fischen, herstellungsverfahren für dieses und seine verwendung

Publications (1)

Publication Number Publication Date
PL1853308T3 true PL1853308T3 (pl) 2012-09-28

Family

ID=36013614

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05818637T PL1853308T3 (pl) 2005-03-02 2005-12-13 Podawany drogą pokarmową preparat farmaceutyczny dla ryb, jego sposób wytwarzania oraz jego zastosowanie

Country Status (14)

Country Link
US (1) US8414947B2 (pl)
EP (1) EP1853308B1 (pl)
JP (1) JP4903166B2 (pl)
CN (1) CN101141978B (pl)
AT (1) ATE547117T1 (pl)
CA (1) CA2599831C (pl)
DE (1) DE102005010288A1 (pl)
DK (1) DK1853308T3 (pl)
ES (1) ES2382553T3 (pl)
NO (1) NO20074949L (pl)
PL (1) PL1853308T3 (pl)
SI (1) SI1853308T1 (pl)
WO (1) WO2006092168A1 (pl)
ZA (1) ZA200707193B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101322228B1 (ko) * 2012-05-04 2013-10-28 대한민국 넙치의 바이러스성 출혈성 패혈증 예방용 백신
CN105797149A (zh) * 2016-04-21 2016-07-27 中国水产科学研究院珠江水产研究所 草鱼细菌性败血症和草鱼细菌性赤皮病二联蜂胶灭活疫苗及制备工艺
WO2023183471A1 (en) * 2022-03-24 2023-09-28 Dutch Creek Nymphing, Llc Composition and method of applying same to increase survival of fish following catch-and-release situations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT388565B (de) 1987-12-02 1989-07-25 Koelbl Oskar Verfahren zur vermehrung des erregers der viralen haemorrhagischen septikaemie (vhs) der forellen in warmblueterzellkulturen
US6274147B1 (en) * 1998-03-31 2001-08-14 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts
TWI220904B (en) * 1998-12-03 2004-09-11 Nat Science Council An immortal cell line derived from grouper Epinephelus coioides and its applications therein
KR20030009344A (ko) * 2000-01-27 2003-01-29 아쿠아 솔루션 인코포레이티드 장내 전달용 조성물
JP2005522203A (ja) * 2002-04-08 2005-07-28 ペロス システムズ テクノロジーズ インコーポレイテッド 生理的反応を調節または免疫応答を誘導するための組成物
GB0216414D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
JP4150631B2 (ja) * 2003-05-30 2008-09-17 川崎三鷹製薬株式会社 魚類冷水病ワクチン

Also Published As

Publication number Publication date
ATE547117T1 (de) 2012-03-15
US8414947B2 (en) 2013-04-09
ZA200707193B (en) 2008-07-30
NO20074949L (no) 2007-11-28
DK1853308T3 (da) 2012-06-25
DE102005010288A1 (de) 2006-09-07
EP1853308A1 (de) 2007-11-14
WO2006092168A1 (de) 2006-09-08
ES2382553T3 (es) 2012-06-11
EP1853308B1 (de) 2012-02-29
US20080317825A1 (en) 2008-12-25
CN101141978B (zh) 2012-06-13
JP2008531610A (ja) 2008-08-14
CA2599831A1 (en) 2006-09-08
SI1853308T1 (sl) 2012-07-31
JP4903166B2 (ja) 2012-03-28
CA2599831C (en) 2014-09-23
CN101141978A (zh) 2008-03-12

Similar Documents

Publication Publication Date Title
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
IL215275A0 (en) Pharmaceutical formulations and methods for treating respiratory tract infections
NZ597378A (en) Treatment of multiple sclerosis with laquinimod
GB0211649D0 (en) Organic compounds
FI2839836T4 (fi) Probiootit käytettäväksi vähennettäessä hengityselintaudin oireita
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
TNSN08279A1 (en) Bayer healthcare ag
FI3347002T3 (fi) Alzheimerin taudin hoitaminen tietyssä potilaspopulaatiossa
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
EP4578461A3 (en) Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa
SE0950390L (sv) System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför
EP2158901A3 (en) Alpha aztreonam lysinate
HUP0102159A2 (hu) Készítmény savtúltengés kezelésére
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
SI1853308T1 (sl) Farmacevtski pripravek za zdravljenje rib ki se ga lahko administrira oralno postopek priprave navedenega pripravka in uporaba le tega
TW200621799A (en) Acylated nonadepsipeptides II
PL374524A1 (pl) Kompozycja na bazie cytrynianu trójetylowego w leczeniu bakteryjnych zakażeń skóry
ATE455789T1 (de) Substituierte nonadepsipeptide
MX2009006670A (es) Composicion farmaceutica que usa el aliskiren y el avosentan.
BRPI0512151A (pt) solução concentrada de sal de sódio monoidratado do tenatoprazol, composição farmacêutica, utilização do sal de sódio monoidratado do tenatoprazol, processo de preparação do sal de sódio monoidratado do tenatoprazol, e composição para administração por via oral do sal de sódio monoidratado do tenatoprazol
WO1999004816A1 (en) Proton pump inhibitor in therapeutic combination with antibacterial substances
JP2021531015A5 (pl)
RU2003101445A (ru) Способ лечения атопической бронхиальной астмы
CN103550160A (zh) 一种消炎药散